TY  - CHAP
M1  - Book, Section
TI  - MONOAMINE OXIDASE INHIBITORS
A1  - Benowitz, Neal L.
A2  - Olson, Kent R.
A2  - Anderson, Ilene B.
A2  - Benowitz, Neal L.
A2  - Blanc, Paul D.
A2  - Clark, Richard F.
A2  - Kearney, Thomas E.
A2  - Kim-Katz, Susan Y.
A2  - Wu, Alan H. B.
PY  - 2018
T2  - Poisoning & Drug Overdose, 7e
AB  - Most  monoamine  oxidase  (MAO)  inhibitors  are  used  primarily  for  severe  depression  resistant  to  other  antidepressant  drugs,  but  are  also  used  to  treat  phobias  and  anxiety  disorders.  First-generation  MAO  inhibitors  include  isocarboxazid  (Marplan),  phenelzine  (Nardil),  and  tranylcypromine  (Parnate).  Newer-generation  MAO  inhibitors  with  lower  toxicity  include  selegiline  (Eldepryl,  Emsam,  Zelapar)  and  rasagiline  (Azilect),  also  used  in  the  treatment  of  Parkinson's  disease,  and  moclobemide  (Aurorix,  Manerix),  a  much  less  toxic  antidepressant  that  is  available  in  many  countries,  but  not  in  the  United  States.  Multiple  other  MAO  inhibitors  are  marketed  outside  the  United  States  to  treat  depression,  anxiety  disorders,  Parkinson's  disease,  and  bacterial  infections.  Serious  toxicity  from  MAO  inhibitors  occurs  with  overdose  or  owing  to  interactions  with  certain  other  drugs  or  foods  (Table  II–41).  
SN  - 
PB  - McGraw-Hill Education
CY  - New York, NY
Y2  - 2024/04/19
UR  - accessmedicine.mhmedical.com/content.aspx?aid=1174606516
ER  -